2nd Priority Review Voucher Summit
- Start Date:
- Thursday, 26 October, 2017
- End Date:
- Friday, 27 October, 2017 5:00pm
- Internal Medicine
Understand the regulatory landscape, valuation approaches and how to successfully develop a drug to secure a priority review voucher. ExL Events' 2nd Priority Review Voucher Summit will take place October 26-27, 2017 at the Hyatt Regency Boston Harbor in Boston, MA. This conference is the ONLY two-day event dedicated to the FDA incentive program that features in-depth industry knowledge on the Neglected Tropical Disease, Rare Pediatric Disease and Medical Countermeasures priority review voucher programs and their respective eligibility requirements.
Attendees will have the opportunity to hear updates on the regulatory and legislative landscape, discuss different valuation models utilized by various stakeholders, and evaluate the role of PRV programs as an active driver for innovation in R&D. Participating Companies From 2016 Include:Adena Partners Management, LLC, Anacor Pharmaceuticals, Bill & Melinda Gates Foundation, Biotechnology Innovation Organization (BIO), Clarus, Drugs for Neglected Diseases (DNDi), Duke University, FDA, Global Alliance for TB Drug Development, Global Health Investment Fund, Janssen, KaloBios, Kids v Cancer, Knight Therapeutics Inc., Medicines Development for Global Health, Medicines for Malaria Venture (MMV), National Organization for Rare Disorders (NORD), Novartis, PATH, Pfizer, Sanofi, and UCB.
URLs:Booking: https://go.evvnt.com/144194-1Brochure: https://go.evvnt.com/144194-2 PriceConference Only - Early Bird - Register by 9/15/2017: USD 1895Conference Only - Standard - Register after 9/15/2017: USD 2095 Category: Conferences | Science, Health & Medicine | Pharmaceuticals
Hyatt Regency Boston Harbor,
101 Harborside Drive,
Conference organized by EXL Events
- +1 917-258-5158